Breaking News

Biogen's new CEO clear-eyed about challenges; telehealth companies prescribing controlled drugs brace for change

    

 

Daily Recap

STAT+: Biogen's new CEO, clear-eyed about company's challenges, prepares to take the reins

By Matthew Herper and Adam Feuerstein and Jason Mast

Photo illustration: STAT

Christopher Viehbacher knows running Biogen may be one of the toughest jobs in the pharmaceutical industry, but is eager for the opportunity.

Read More

STAT+: Telehealth companies that prescribed controlled substances during the pandemic brace for business to change

By Mohana Ravindranath and Katie Palmer

Adobe

Companies like Bicycle Health and Ophelia could prescribe controlled substances fully online during the pandemic, but that may change.

Read More

Opinion: Lessons from polio about the need to vaccinate kids against Covid-19

By Lynn R. Goldman and Amanda D. Castel

FREDERIC J. BROWN/AFP via Getty Images

There are some parallels between polio and Covid-19 in kids. A big one is the importance of vaccinating kids against each disease.

Read More

STAT+: Unexpected troubles hit large medical billing firm R1 RCM, part-owned by Ascension

By Bob Herman

Adobe

The stock price of R1 RCM tanked by roughly 50% this week after the medical billing company reported an unexpected $30 million loss.

Read More

Opinion: Violence against health care workers is on the rise. They deserve protection

By Mary Beth Kingston and Christopher S. Kang

Damian Dovarganes/AP

Violent attacks have become frighteningly common in America's hospitals and other health care settings. Workers need protection from it.

Read More

Friday, November 11, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments